125 related articles for article (PubMed ID: 7881035)
1. Expression of GFAP in the striatum and its projection areas in response to striatal quinolinic acid lesion in rats.
Block F; Schwarz M
Neuroreport; 1994 Nov; 5(17):2237-40. PubMed ID: 7881035
[TBL] [Abstract][Full Text] [Related]
2. Remote microglial activation in the quinolinic acid model of Huntington's disease.
Töpper R; Gehrmann J; Schwarz M; Block F; Noth J; Kreutzberg GW
Exp Neurol; 1993 Oct; 123(2):271-83. PubMed ID: 8405289
[TBL] [Abstract][Full Text] [Related]
3. Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes.
Brickell KL; Nicholson LF; Waldvogel HJ; Faull RL
J Chem Neuroanat; 1999 Oct; 17(2):75-97. PubMed ID: 10585160
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Chen Q; Reiner A
Exp Neurol; 1997 Aug; 146(2):444-57. PubMed ID: 9270055
[TBL] [Abstract][Full Text] [Related]
5. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
[TBL] [Abstract][Full Text] [Related]
6. Association between inflammation and nigral neuronal damage following striatal excitotoxic lesion.
Block F; Loos M; Frohn C; Schwarz M
Brain Res; 2004 Feb; 998(1):29-35. PubMed ID: 14725965
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of somatosensory evoked potentials in the quinolinic acid model of Huntington's disease: evidence that basal ganglia modulate sensory cortical input.
Schwarz M; Block F; Töpper R; Sontag KH; Noth J
Ann Neurol; 1992 Sep; 32(3):358-64. PubMed ID: 1329611
[TBL] [Abstract][Full Text] [Related]
8. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults.
Hanbury R; Ling ZD; Wuu J; Kordower JH
J Comp Neurol; 2003 Jun; 461(3):307-16. PubMed ID: 12746870
[TBL] [Abstract][Full Text] [Related]
9. Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats.
Pierozan P; Zamoner A; Soska AK; Silvestrin RB; Loureiro SO; Heimfarth L; Mello e Souza T; Wajner M; Pessoa-Pureur R
Exp Neurol; 2010 Jul; 224(1):188-96. PubMed ID: 20303347
[TBL] [Abstract][Full Text] [Related]
10. Visual evoked potentials in the rat quinolinic acid model of Huntington's disease.
Schwarz M; Block F
Neurosci Lett; 1993 Apr; 152(1-2):81-3. PubMed ID: 8390629
[TBL] [Abstract][Full Text] [Related]
11. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes.
Björklund H; Olson L; Dahl D; Schwarcz R
Brain Res; 1986 Apr; 371(2):267-77. PubMed ID: 2938667
[TBL] [Abstract][Full Text] [Related]
12. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum.
Levivier M; Gash DM; Przedborski S
Neuroscience; 1995 Nov; 69(1):43-50. PubMed ID: 8637631
[TBL] [Abstract][Full Text] [Related]
13. Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.
Amaral AU; Seminotti B; da Silva JC; de Oliveira FH; Ribeiro RT; Vargas CR; Leipnitz G; Santamaría A; Souza DO; Wajner M
Neurotox Res; 2018 Apr; 33(3):593-606. PubMed ID: 29235064
[TBL] [Abstract][Full Text] [Related]
14. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
15. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
Bordelon YM; Chesselet MF
Neuroscience; 1999; 93(3):843-53. PubMed ID: 10473250
[TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid.
Schiefer J; Töpper R; Schmidt W; Block F; Heinrich PC; Noth J; Schwarz M
J Neuroimmunol; 1998 Aug; 89(1-2):168-76. PubMed ID: 9726839
[TBL] [Abstract][Full Text] [Related]
17. Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice.
MacGibbon GA; Hamilton LC; Crocker SF; Costain WJ; Murphy KM; Robertson HA; Denovan-Wright EM
J Neurosci Res; 2002 Feb; 67(3):372-8. PubMed ID: 11813242
[TBL] [Abstract][Full Text] [Related]
18. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.
Joel D; Ayalon L; Tarrasch R; Weiner I
Mov Disord; 2003 Dec; 18(12):1499-507. PubMed ID: 14673887
[TBL] [Abstract][Full Text] [Related]
19. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
20. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
